Research Area Affiliations
Dr. Aaron Remenschneider’s current research focus is in the area of additive manufacturing (3-D printing) and its application to help solve long-standing problems in otologic disease. He works as the clinical and surgical partner in collaboration with a biofabrication laboratory (Wyss Institute/Harvard University) and the middle ear mechanics group at Mass. Eye and Ear. This multidisciplinary team designs and fabricates otologic prostheses that have direct clinical potential. He is interested in the wound healing potential of novel devices for middle ear reconstruction and investigating prostheses biologic response through otopathologic techniques.
Dr. Remenschneider has also performed research on clinical and surgical outcomes in otology. In addition to a medical doctorate, he holds a Masters of Public Health degree, with a focus on biostatistics, research study design and patient centered outcomes. He has an interest in better understanding the etiology of otologic disease through otopathologic techniques, designing effective methods of treating, and rehabilitating otologic conditions and measuring the outcomes of these interventions. Dr. Remenschneider was the lead investigator for the multi-institutional, city-wide Otologic Outcomes Study following the Boston Marathon bombings.
Design, fabrication and in vitro testing of novel three-dimensionally printed tympanic membrane grafts. Kozin ED, Black NL, Cheng JT, Cotler MJ, McKenna MJ, Lee DJ, Lewis JA, Rosowski JJ, Remenschneider AK. Hearing Research. 2016 Mar 16.
Health utility improves after surgery for superior canal dehiscence syndrome. Remenschneider AK, Owoc M, Kozin ED, McKenna MJ, Lee DJ, et al. Otol & Neurotol. 2015.
Three-dimensional printed prosthesis for repair of superior canal dehiscence. Kozin ED, Remenschneider AK, Cheng S, Nakajima HH, Lee DJ. Otolaryngol Head Neck Surg. 2015. 153(4):616-9.
Histopathology of idiopathic lateral skull base defects. Remenschneider AK, Kozin ED, Curtin H, Santos F. Laryngoscope. 2015. 125(8):1798-806.
EQ-5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis. Remenschneider AK, Scangas G, Meier JC, Gray ST, Holbrook EH, et al. Laryngoscope. 2015. 125(5):1056-61.
Otologic outcomes after blast injury: the Boston Marathon experience. Remenschneider AK, Lookabaugh S, Aliphas A, Brodsky JR, Devaiah AK, et al. Otol & Neurotol. 2014. 35(10):1825-34.
View a complete list of publications on pubmed.gov.